Steve Mertens

Chief Technology Officer at NeuroOne Medical Technologies Corporation

Steve Mertens has extensive work experience in various roles within the medical technology industry. Steve is currently the Chief Technology Officer at NeuroOne Medical Technologies Corporation, a position they have held since 2019. Prior to this, they served as the Sr. Vice President of R&D and Operations at NUVAIRA, Inc. from 2012 to 2018.

From 2001 to 2012, Mertens worked at Boston Scientific, starting as the Vice President of R&D and later becoming the Sr. Vice President of R&D. During their time at Boston Scientific, they managed diverse technology groups and identified new technologies across various divisions. Steve also coordinated multiple R&D groups working in cardiology, rhythm, vascular, and electrophysiology, with expertise in polymers, metals, pharmaceuticals, and electronics.

Before joining Boston Scientific, Mertens worked at Scimed and Scimed Life Systems. At Scimed, they served as the Director of R&D, specializing in balloon catheters and vascular access. At Scimed Life Systems, they held the position of Manufacturing/Quality Engineer and Manager, responsible for process development, quality engineering, and manufacturing of various medical devices.

Mertens began their career at HTI, first as a Manufacturing Engineer and later as a Development Engineering Supervisor. In these roles, they were involved in flexible circuit assembly, disk drive assembly, and electronic testing.

Overall, Steve Mertens has a diverse and extensive background in medical technology, with experience in R&D, operations, manufacturing, and engineering supervision.

Steve Mertens has a Bachelor's degree in Chemical Engineering from the University of Minnesota, which they obtained from 1981 to 1985. Steve also holds a Master's degree in Business Administration from St. Thomas University, which they acquired from 1992 to 1998.

Links

Previous companies

NUVAIRA logo
TDK logo
Boston Scientific logo

Timeline

  • Chief Technology Officer

    March, 2019 - present

View in org chart